Who to call at Evotec, and when
Fundz watches for the moments Evotec starts buying, and tells you who to reach.
- An alert the day Evotec raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Evotec, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Evotec. With Fundz connected, it knows.
Evotec receives $2.9m grant from Gates Foundation to enhance stem cell-based drug safety testing.
Contract Type
agreement
Description
Evotec has secured a $2.9m grant from the Gates Foundation to advance its stem cell-based New Approach Methodologies aimed at improving drug safety testing. This funding supports the continuation of a project that has already screened over 5000 compounds for developmental toxicity risks.
Quick answer
Evotec receives $2.9m grant from Gates Foundation to enhance stem cell-based drug safety testing. (November 17, 2026). Evotec is based in Hamburg, Hamburg, Germany.
- What agreement did Evotec announce on November 17, 2026?
- Evotec has secured a $2.9m grant from the Gates Foundation to advance its stem cell-based New Approach Methodologies aimed at improving drug safety testing. This funding supports the continuation of a project that has already screened over 5000 compounds for developmental toxicity risks.
- What does Evotec do?
- Evotec is a biotechnology company that is committed to advancing drug discovery and development.
- Where is Evotec based?
- Evotec is based in Hamburg, Hamburg, Germany.
- Which similar companies announced agreements around the same time?
- Pfizer (November 14, 2026), Sino Biopharmaceutical (November 13, 2026), Spektus Pharma (November 13, 2026) and Daiichi Sankyo Healthcare Co (November 10, 2026) also announced agreements within 45 days of Evotec.
Source: Fundz verified event record.
Other recent agreements in Pharmaceutical and Biotechnology
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- Pfizer Partners with Blackstone Life Sciences to Co-Fund $1.5 Billion Development for Berobenatide Obesity Drug. (November 14, 2026)
- Sino Biopharmaceutical Partners with Boehringer Ingelheim in a $358 Million Oncology Deal (November 13, 2026)
- Spektus Pharma and GEBRO Holding Form Partnership for Global Commercialisation of ActraFlex® (November 13, 2026)
- Daiichi Sankyo and iDEL Therapeutics Forge Global Research Partnership for Cancer Drug Development. (November 10, 2026)
- Essential Pharma and Nordmark establish partnership for UK availability of Norzyme® capsules for pancreatic insufficiency. (November 9, 2026)
- Edesa Biotech Enters Collaboration and License Agreement with Kyorin Pharmaceutical (November 9, 2026)
Related People
Evotec signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.